Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization. It comes at a critical time for Australia’s medical research sector.
The focus of the agenda this year will be on translation and commercialization of homegrown Australian research, improving drug development and clinical trials in Australia as well as the impact of COVID-19 on the landscape.
The Federal Health Minister asserts that Australia has an opportunity to become a world leader in future medical research. Other experts have echoed the sentiment that we have a golden opportunity to attract new medical research, technology and clinical trials to Australia and added that there is also an opportunity to grow pandemic-related research and other areas. If this is true, how can we capture this opportunity? What needs to change?
Bio Connections Australia provides an important platform for further discussion and debate on what the challenges, opportunities and realities may be for drug development, clinical trials and medical research in Australia.
PRICES FOR THIS EVENT WILL SOON BE GOING UP. THESE ARE NEVER BEFORE SEEN PRICES WHICH ARE ONLY AVAILABLE FOR A LIMITED TIME. REGISTER TODAY AT THE LOWEST RATE POSSIBLE.
2019 VIC Australian of the Year and Managing Director, Medicines Development for Global Health
VP and Head, AbbVie Ventures, Boston/Chicago
Dr Michelle Perugini
Co-Founder and CEO, Presagen and Life Whisperer
Dr Glenn Begley
Dr Anand Gautam
Executive Director & Emerging Science Lead, Emerging Science & Innovation, Asia & APAC (Australia & New Zealand), Pfizer Worldwide R&D
Dr Mark Ashton
Executive Director, IP Commercialisation, UniQuest
Professor Sabe Sabesan
Director of Medical Oncology, Townsville Cancer Centre, Co-Chair, Australian Teletrial Consortium, Clinical Oncology Society of Australia
Associate Professor Tam C. Nguyen
Deputy Director of Research, St Vincent's Hospital Melbourne
CEO, HAVAH Therapeutics
Professor Paul Young
Professor of Virology and Head of School, School of Chemistry and Molecular Biosciences, The University of Queensland
Dr Katharine Giles
CEO & Managing Director, OncoRes Medical
Clinical Trials Director, TrialHub, Alfred Health
Associate Professor Kate Burbury
Haematologist and Disease Group Lead: Myeloproliferative Disorders/Chronic Myeloid Leukaemia, Peter MacCallum Cancer Centre
Dr Laura Issa
Business Development, Search & Evaluation Lead, ANZ, AbbVie Pty Ltd
Venture Partner, One Ventures
MD Australia, IP Group
Director, Commercialisation (Life Sciences), Monash University
Dr Tina Soulis
PhD, BSc, MAICD, Chief Executive Officer, Neuroscience Trials Australia
Rosa Gonzalez Galindo
Sr Vice President Clinical Development, Immunology and Inflammation, Syneos Health
Program Director, CT:IQ
EVP, Head of Product, Medidata, a Dassault Systèmes company
Bio Connections Australia Goes Virtual
The health and safety of our delegates, speakers and staff is our top priority. That is why Bio Connections will now run as a virtual event. We are delighted to present an innovative and creative format for the event which allows for greater participation from delegates both across Australia and around the world as their participation is no longer inhibited by the cost and time required for travel to Australia.
This virtual event will be hosted on a sophisticated, fully interactive platform that encourages communication through instant chat and video meetings. This event has a longer life span, having access to the excellent networking capabilities for one month after, but also access to the quality content after the event.
The content will be world class with a selection of local and international industry leaders and experts and the ability to directly ask questions and engage virtually from the safety and comfort of your own home or workplace anywhere in the world. The networking will be more productive and the business development opportunities will be measurable and impactful with a streamlined platform to promote your solution and connect with the right people.
ON DEMAND CONTENT
Gain access to live content of the conference along with quality matchmaking and Q&A opportunities! Hear from leading industry experts live and schedule your sessions with a virtual agenda, completely customizable to opt into any panels offered across the event.
With intent based and AI powered virtual matchmaking, you will meet quality leads over 1:1 meetings to make meaningful connections.
View and interact with other participants and speakers during the sessions with live Q&A, chats and polls.
A virtual showcase of players in the industry for you to view product demos, network and take your business to the next level.
See below a quick 3-minute video that showcases how the virtual platform works:
Bio Box Australia
Bio Box Australia is a video-on-demand service providing a deeper dive on key topics, themes and questions relating to Bio Connections Australia. Bio Box will explore a wide range of topic areas including drug discovery and development, clinical trials, translating research, commercialization, going global strategies, capital raising and much more! It offers a range of perspectives from Australia and abroad.
Each Bio Box Australia episode be different with a mix of fireside chats, panels, presentations, bespoke digital theatre recordings and much more! Each month we release a new episode on a different topic.
The best part? This content is available in the lead-up to, during and after the Bio Connections Australia event each year so you can keep coming back!
NEXT UPCOMING BIO BOX:
Episode 6: Understanding & Navigating the US Market
Episode 7: Planning for Phase 1 Clinical Trials in Australia in the COVID-19 Era
Bio Box Speakers
Nicoletta Muner, Managing Director, Canary Regulatory Affairs
Adriana Stefancic, Managing Director & Principal Consultant, Adriaus Consulting
Prof. Dean Ho, Provost’s Chair Professor, Director of The N.1 Institute for Health (N.1), Director of the Institute for Digital Medicine (WisDM), and Head of the Department of Biomedical Engineering at the National University of Singapore
Rosa Gonzalez Galindo, Sr Vice President Clinical Development, Immunology and Inflammation, Syneos Health
Michael Tucker, Senior mHealth Solutions Specialist, Medidata, a Dassault Systèmes company
Dr Tina Soulis, Chief Executive Officer, Neuroscience Trials Australia